Mastic for treating herpes zoster and preparation method thereof

The technology of herpes zoster and ointment is applied in the field of ointment for treating herpes zoster and its preparation, which can solve the problems of inability to timely and effectively control the disease condition, dependence on antibiotics, and high treatment costs, and achieves the promotion of drug absorption, enhancement of penetration, and price. low cost effect

Inactive Publication Date: 2012-08-22
鲁道宗
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently there are various ointments and injections for this kind of herpes zoster, but many of them rely on antibiotics and cannot control the disease in a timely and effective manner. Even after the recovery, many patients still have long-term pain in the subcutaneous peripheral nerves of the affected area, and the treatment cost is also high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] The raw materials of the present embodiment are commercially available products, and the raw materials are taken according to the following parts by weight:

[0025] 2 parts of realgar, 1 part of sulfur, 1 part of light powder, 1 part of xuanming powder, 1 part of metronidazole powder, 1 part of compound acetylsalicylic acid powder, 15 parts of fluocinolone acetate cream.

[0026] Take the three flavors of sulfur, realgar and light powder, process and grind them into fine powder, the powder particle size is about 50 mesh, then add Xuanming powder, metronidazole powder and compound acetylsalicylic acid powder to mix, and finally add fluocinolone acetate cream Stir well to form an ointment.

Embodiment 2

[0028] The raw materials of the present embodiment are commercially available products, and the raw materials are taken according to the following parts by weight:

[0029] 4 parts of realgar, 3 parts of sulfur, 3 parts of light powder, 3 parts of Xuanming powder, 2 parts of metronidazole powder, 3 parts of compound acetylsalicylic acid powder, 25 parts of fluocinolone acetate cream.

[0030] Take the three flavors of sulfur, realgar and light powder, process and grind them into fine powder, the powder particle size is about 100 mesh, then add Xuanming powder, metronidazole powder and compound acetylsalicylic acid powder to mix, and finally add fluocinolone acetate cream Stir well to form an ointment.

Embodiment 3

[0032] The raw materials of the present embodiment are commercially available products, and the raw materials are taken according to the following parts by weight:

[0033] 3 parts of realgar, 2 parts of sulfur, 2 parts of light powder, 2 parts of Xuanming powder, 1.5 parts of metronidazole powder, 2 parts of compound acetylsalicylic acid powder, 20 parts of fluocinolone acetate cream.

[0034] Take sulfur, realgar and light powder, process and grind them into fine powder, the powder particle size is about 75 mesh, then add Xuanming powder, metronidazole powder and compound acetylsalicylic acid powder to mix, and finally add fluocinolone acetate cream Stir well to form an ointment.

[0035] Clinical data: For 100 clinical cases, 50 cases were randomly selected as the comparison group, and conventional treatment methods were used, that is, hanging anti-inflammatory potions and taking anti-inflammatory drugs for treatment.

[0036] Another 50 cases were used as the test group, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses mastic for treating herpes zoster and a preparation method thereof, which include the following components by weight: 2 to 4 parts of realgar, 1 part to 3 parts of sulfur, 1 part to 3 parts of calomel, 1 part to 3 parts of compound of glauber-salt and liquorice, 1 part to 2 parts of metronidazole powder, 1 part of 3 parts of compound acetylsalicylic acid powder and 15 parts to 25 parts of fluocinonide emulsifiable paste. The mastic is low in price and good in treating effect. Intense pain or pruritus can be released or disappear after the mastic is applied for about half an hour, and the mastic is capable of quickly controlling spreading and development of herpes. The herpes are shrunk and scab after two or three days of red spot fading of the skin, and no adverse effects are caused. The mastic is capable of effectively killing germs such as herpes zoster virus and staphylococcus aureus and can be widely used in treatment of herpes zoster, impetigo (crusted tetter), leukoplakia vulvae, psoriasis and the like.

Description

technical field [0001] The invention relates to an externally used medicine for mainly treating herpes zoster and a preparation method thereof, in particular to an ointment for treating herpes zoster and a preparation method thereof. Background technique [0002] Herpes zoster is an acute herpetic skin disease caused by viral infection. Clinically, it is mainly manifested as clustered blisters on erythema, which are painful. After the onset, the rash will spread rapidly, and the skin of the affected area will be in severe pain like burning. The blisters are about the size of mung beans, transparent and clear. After a few days, the blisters are cloudy, rupture and form erosions, and then dry and scab. In the dorsal root ganglia of the spinal cord, once the immune function is weakened, the herpes zoster virus will attack again. The course of the virus lasts about two weeks. The whole process is accompanied by obvious neuralgia, and the patient often suffers from unbearable pai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/36A61K9/06A61P31/22A61K33/28A61K33/04A61K31/616A61K31/58A61K31/4164
Inventor 鲁道宗
Owner 鲁道宗
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products